indirubin has been researched along with Cancer of Prostate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Renaud, M; Rivest, P; Sanderson, JT | 1 |
Dai, F; Dong, Y; He, L; Lai, L; Liu, M; Lu, B; Song, Y; Wu, Y; Yi, Z; Zhang, J; Zhang, X | 1 |
Digiovanni, J; Miyoshi, K; Sano, S; Takaishi, M | 1 |
Buettner, R; Cheng, JQ; Eisenbrand, G; Hippe, F; Jove, R; Kim, D; Merz, KH; Muehlbeyer, S; Nam, S; Turkson, J; Vatter, S | 1 |
4 other study(ies) available for indirubin and Cancer of Prostate
Article | Year |
---|---|
Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations.
Topics: Androgen Antagonists; Antibiotics, Antineoplastic; Apoptosis; beta Catenin; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Luciferases; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Time Factors; Tumor Cells, Cultured | 2011 |
Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell.
Topics: Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Cell Line; Cell Line, Tumor; Endothelial Cells; Humans; Indoles; Janus Kinases; Male; Mice; Prostatic Neoplasms; Signal Transduction; STAT3 Transcription Factor; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2011 |
Attenuation of psoriasis-like skin lesion in a mouse model by topical treatment with indirubin and its derivative E804.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Female; Humans; Indoles; Keratinocytes; Male; Mice; Oximes; Prostatic Neoplasms; Psoriasis; Sequence Analysis, DNA; Signal Transduction; Skin; Up-Regulation | 2012 |
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.
Topics: Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; DNA-Binding Proteins; Female; Growth Inhibitors; Humans; Indoles; Inhibitor of Apoptosis Proteins; Kinetics; Male; Microtubule-Associated Proteins; Neoplasm Proteins; Phosphorylation; Prostatic Neoplasms; Signal Transduction; STAT3 Transcription Factor; Survivin; Trans-Activators | 2005 |